PGAM5 acts as a key mediator of lung fibrosis by disrupting mitochondrial homeostasis

Ganzleben I, He GW, Günther C, Prigge ES, Richter K, Rieker R, Mougiakakos D, Neurath M, Becker C (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

European Respiratory Journal European Respiratory Society

Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTD

City/Town: SHEFFIELD

Conference Proceedings Title: EUROPEAN RESPIRATORY JOURNAL

Event location: Madrid ES

DOI: 10.1183/13993003.congress-2019.PA595

Authors with CRIS profile

Ingo Ganzleben Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Claudia Günther Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Ralf Rieker Institute of Pathology Dimitrios Mougiakakos Professur für Hämatologie/Onkologie mit dem Schwerpunkt Tumorimmunologie Markus Neurath Lehrstuhl für Innere Medizin I Christoph Becker Professur für Molekulare Gastroenterologie

Involved external institutions

Ruprecht-Karls-Universität Heidelberg DE Germany (DE) Deutsches Krebsforschungszentrum (DKFZ) DE Germany (DE)

How to cite

APA:

Ganzleben, I., He, G.-W., Günther, C., Prigge, E.-S., Richter, K., Rieker, R.,... Becker, C. (2019). PGAM5 acts as a key mediator of lung fibrosis by disrupting mitochondrial homeostasis. In EUROPEAN RESPIRATORY JOURNAL. Madrid, ES: SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD.

MLA:

Ganzleben, Ingo, et al. "PGAM5 acts as a key mediator of lung fibrosis by disrupting mitochondrial homeostasis." Proceedings of the European-Respiratory-Society (ERS) International Congress, Madrid SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD, 2019.

BibTeX: Download